Sg3 Management, LLC Atreca, Inc. Put Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$4.91 - $9.07 $564,650 - $1.04 Million
-115,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$7.82 - $13.8 $899,300 - $1.59 Million
115,000 New
115,000 $980,000

Others Institutions Holding BCEL

# of Institutions
2
Shares Held
30.6K
Call Options Held
0
Put Options Held
0
View Full List

About Atreca, Inc.

BCEL Quotes by TradingView
  • Ticker BCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,876,000
  • Description
  • Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...
More about BCEL
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email